NCT04146064 2023-06-05Breathomics as Predictive Biomarker for Checkpoint Inhibitor ResponseUniversity Health Network, TorontoUnknown425 enrolled
NCT05823246 2023-05-26Safety and Efficacy Study of QLF31907 in Advanced Melanoma and Urothelial CarcinomaQilu Pharmaceutical Co., Ltd.Phase 2 Unknown66 enrolled
NCT04773951 2021-08-24A Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JS004 in Advanced Solid TumorsShanghai Junshi Bioscience Co., Ltd.Phase 1 Unknown156 enrolled
NCT03544723 2020-06-09Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.MultiVir, Inc.Phase 2 Unknown40 enrolled